| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |